Myriad expands pharma service offering by introducing Personalis’ ImmunoID NeXT® platform to its pharmaceutical partners who use MyRisk® Hereditary Cancer Test, BRACAnalysis CDx® and/or MyChoice® CDx cancer tests […]
PhotoPharmics Secures $16 Million Investment Led by Kickstart to Fund Pivotal Clinical Trial for FDA Market Authorization […]
Seek Labs’ integrated molecular diagnostic platform brings true point-of-care testing to the patient. […]
Revolutionizing Data Collection in Cardiology with Proprietary Wireless Ecosystem […]
Unveiling the Power of Epigenetics in Male Fertility: A New Horizon Beyond Semen Analysis […]
The company expects to receive U.S. approval late next year. […]
Company Ranks Top 2 in Healthcare Equipment and Services Industry […]
Enhances Thermo Fisher’s Capabilities in the High-Growth Proteomics Market with the Addition of Highly Differentiated Solutions […]
After the release of the first IVDR certificate at the beginning of the year ELITech Group continues to expand its portfolio of IVDR-certified PCR assays to support European diagnostic laboratories. […]
CLP Magazine recently interviewed Kristen Smith, senior medical science liaison at bioMérieux […]
Once-daily, steroid-free roflumilast foam 0.3% demonstrated significant improvements in both scalp and body psoriasis […]
ARUP Healthcare Advisory Services Wins a Third ASCP Choosing Wisely Champion Award […]